Current Status, Opportunities and Challenges of Rare Endocrine and Metabolic Diseases
10.12376/j.issn.2097-0501.2023.03.001
- VernacularTitle:内分泌代谢罕见病研究现状、机遇与挑战
- Author:
Huixiao WU
1
,
2
,
3
;
Zongyue LI
1
,
2
,
3
;
Chao XU
1
,
2
,
3
;
Jiajun ZHAO
1
,
2
,
3
Author Information
1. Key Laboratory of Endocrine Glucose &
2. Lipids Metabolism and Brain Aging, Ministry of Education
3. Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.Shandong Key Laboratory of Endocrinology and Lipid Metabolism in Shandong Province, Jinan 250021, China.Research Center of Stem Cell and Engineering Gene Therapy for Endocrine and Metabolic Diseases in Shandong Province, Jinan 250021, China.
- Publication Type:Journal Article
- Keywords:
rare endocrine and metabolic diseases;
diagnosis;
mechanism;
treatment
- From:
JOURNAL OF RARE DISEASES
2023;2(3):319-324
- CountryChina
- Language:Chinese
-
Abstract:
The rare endocrine and metabolic diseases, due to their varieties, face many challenges in the study of clinical diagnosis, pathogenesis, and treatment. In the past a couple of years, the research on rare endocrine and metabolic diseases has been gradually improved. The diagnosis has made great progress. The research into molecular mechanism of rare endocrine and metabolic diseases has significantly advanced. The effort in exploring the breakthroughs and progress in therapeutic methods based on the pathogenesis of the diseases has also made. This article provides a brief overview of the current status of research into diagnosis, mechanism, and treatment of rare endocrine and metabolic diseases. In addition, the article points out the problems and challenges and proposes future possibilities.
